Kenneth Hillan Insider Trading
Get free email notifications about insider trading for Kenneth Hillan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kenneth Hillan. Kenneth Hillan is a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and an Chief Executive Officer in Achaogen Inc ($AKAO) and a See Remarks in Achaogen Inc ($AKAO) and a Director in Zymeworks Inc. ($ZYME) and a Director in Relypsa Inc ($RLYP).
Address: C/O ACHAOGEN, INC. 7000 SHORELINE COURT, #371 SOUTH SAN FRANCISCO 94080 CA
Companies in which Kenneth Hillan is an Insider
Achaogen, Inc.
Trading Symbol: AKAOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: See Remarks, Chief Executive Officer
Holdings: 248,128 shares
Current Value: $4,677,213
Latest Transaction: Jun 29 2018
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Relypsa Inc
Trading Symbol: RLYPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: Director
Holdings: 2,250 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANGAMO THERAPEUTICS, INC
Trading Symbol: SGMOIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Kenneth Hillan: Director
Holdings: 23,200 shares
Current Value: $89,320
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zymeworks Inc.
Trading Symbol: ZYMEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Kenneth Hillan: Director
Holdings: 0 shares
Latest Transaction: May 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Kenneth Hillan
Sentiment: All, AKAO, RLYP, SGMO, ZYME
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | ZYME | Zymeworks Inc. | Hillan Kenneth J. | Director | Option Exercise | A | 29.49 | 9,000 | 265,410 | 9,000 | |
Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Option Exercise | A | 11.19 | 16,400 | 183,516 | 16,400 | |
Mar 01 2021 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Grant | A | 0.00 | 8,200 | 0 | 23,200 | 15 K to 23.2 K (+54.67 %) |
Sep 11 2020 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Option Exercise | A | 10.43 | 30,000 | 312,900 | 30,000 | |
Sep 11 2020 | SGMO | SANGAMO THERAPEUTI ... | Hillan Kenneth J. | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
May 12 2020 | ZYME | Zymeworks Inc. | Hillan Kenneth J. | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
May 08 2019 | ZYME | Zymeworks Inc. | Hillan Kenneth J. | Director | Option Exercise | A | 19.11 | 10,000 | 191,100 | 10,000 |